Literature DB >> 870238

Myocardial function and coronary blood flow response to acute ischemia in chronic canine diabetes.

B Haider, S S Ahmed, C B Moschos, H A Oldewurtel, T J Regan.   

Abstract

To examine the influence of preexistent diabetes mellitus on left ventricular performance and coronary blood flow responses to acute ischemia, mild normoglycemic diabetes was induced in nine mongrel dogs after three doses of alloxan, (20 mg/kg, iv), at monthly intervals. Hemodynamic measurements and coronary blood flow (85Kr clearance) were obtained before and after the onset of ischemia. This was produced by occlusion of the proximal left anterior descending coronary artery via a balloon-type catheter in nine intact anesthetized diabetic dogs and 10 nondiabetic dogs. During the 1st hour of ischemia in the diabetic group, the end-diastolic pressure rose from 7 +/- 1.1 (mean +/- SE) mm Hg to 23.8 +/- 2.3 without a significant increase of end-diastolic volume. In controls end-diastolic pressure rose from 8.6 +/- 1.1 mm Hg to 15.3 +/- 1.4, and end-diastolic volume was significantly increased, so that the ratio of end-diastolic pressure and volume was significantly higher in the diabetic group (P less than 0.005). Although indices of contractility did not differ, stroke volume and work reductions were significantly greater in diabetics, despite the fact that coronary blood flow was reduced to a similar extent. Size of the ischemic areas appeared comparable as judged by distribution of dye injected distal to the occlusion. Since potassium loss and sodium gain in the inner and outer layers of ischemic tissue did not differ between the two groups, the intensity of ischemia seemed similar. Glycogenolysis was unimpaired in the diabetic ischemic muscle but triglyceride levels remained elevated. Morphologically the diabetic myocardium was characterized by a diffuse accumulation of periodic acid-Schiff-positive glycoprotein in the interstitium, which was thought to limit diastolic filling of the ischemic ventricle and to contribute to the substantial reduction of ventricular performance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870238     DOI: 10.1161/01.res.40.6.577

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  16 in total

1.  A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension.

Authors:  M Kawaguchi; M Techigawara; T Ishihata; T Asakura; F Saito; K Maehara; Y Maruyama
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

2.  The concentration of non-esterified fatty acids in biopsies from normoxic dog myocardium.

Authors:  G J van der Vusse; T H Roemen; F W Prinzen; R S Reneman
Journal:  Basic Res Cardiol       Date:  1981 Jul-Aug       Impact factor: 17.165

Review 3.  Metabolic abnormalities in the diabetic heart.

Authors:  Gary D Lopaschuk
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

Review 4.  Treatment of heart failure in patients with diabetes mellitus.

Authors:  Steven J Lavine; Steven D Gellman
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Effects of epinephrine on underperfusion-reperfusion injuries in diabetic and non-diabetic rat hearts.

Authors:  Makie Higuchi; Keiko Hirata; Ayako Yamashita; Katsuhide Nishi
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

6.  Arrhythmia susceptibility and myocardial composition in diabetes. Influence of physical conditioning.

Authors:  S Bakth; J Arena; W Lee; R Torres; B Haider; B C Patel; M M Lyons; T J Regan
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

7.  Isolation and characterization of mitochondria from goat hearts.

Authors:  Tester F Ashavaid; Neena S Kumbhat
Journal:  Indian J Clin Biochem       Date:  2005-01

8.  Coronary blood flow in chronic insulin-dependent diabetic dogs.

Authors:  K W Small; E Stefansson; D L Hatchell
Journal:  Acta Diabetol Lat       Date:  1989 Oct-Dec

9.  Vectorcardiographic evaluation of diabetic cardiomyopathy and of its contributing factors.

Authors:  E Vitolo; S Madoi; C Sponzilli; M Palvarini; D Silvestri; D Castini; A Morabito
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

10.  Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease.

Authors:  S M Factor; R Bhan; T Minase; H Wolinsky; E H Sonnenblick
Journal:  Am J Pathol       Date:  1981-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.